Combination of Rituximab with subcutaneous placebo clinical trials

Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia

This study looks at a new way to treat a blood problem called ITP in adults. It combines an existing drug, rituximab, with a new one, belimumab, to see if it works better than rituximab alone in boosting platelet counts.